Apheresis only came to the attention of the ME/CFS community a couple of years ago. It’s big in some countries like Germany, but from what I can tell, is hardly used in the U.S. to treat ME/CFS or long COVID. If the authors of a couple of recent papers have...
“A lot of what’s happening in CFS is probably not happening in the blood.” Amy Proal If we’re going to get to the promised land, it’s probably going to come through better technology – which is a good thing – as technological...
The bottom line is always treatments. Long COVID has brought a ton of interest to post-infectious illnesses. Researchers are asking whether they are actually autoimmune diseases, how big of a role coagulation or gut microbiome problems play, if viral reactivation is...
The building is dark – the doors are locked – everything has been shut down. It’s early 2020 and the coronavirus pandemic has struck. A figure walks down the street, pauses – briefly peers into the entrance – and moves on. He turns left...
Another week – another fascinating drug connection pops up in long COVID. A preprint of a long-COVID study, “Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine – and the development of Long Covid over a 10-month...
The intense interest in long COVID should spur many repurposed drug trials. If there’s one thing we might hope for – and expect – to happen over the next year or two is for a flurry of repurposed drugs to get trialed in long COVID. It just makes...
